Cann Group Limited

The company has established research and cultivation facilities in Melbourne and is striving to provide access to medicinal cannabis for Australian patients. Cann Group has executed collaboration agreements that will enable it to establish a leading position in plant genetics, breeding, extraction, analysis and production techniques required to facilitate the supply of medicinal cannabis for a range of diseases and medical conditions. We were issued with Australia’s first medicinal cannabis research license in February 2017, in addition to Australia’s first medicinal cannabis cultivation license in March 2017.